OCT 21, 2021 4:30 PM PDT

FDA approves mixing and matching COVID booster shots

WRITTEN BY: J. Bryce Ortiz

On Wednesday, the United States Food and Drug Administration (FDA) approved Americans to be given a different COVID-19 “booster” vaccine than the original vaccination they received. In other words, an individual who originally received both doses of the Pfizer vaccine can now receive the Moderna vaccine as a booster, for example. This is termed a “mix and match” approach and is an important step in combating COVID-19. 

Acting FDA Commissioner Dr. Janet Woodcock said, “the available data suggest waning immunity in some populations who are fully vaccinated. The availability of [the] authorized booster is important for continued protecting against COVID-19 disease.” However, the FDA left regulations in place regarding who can receive the booster vaccines that some have found confusing. Current data and regulations state that booster doses of the COVID-19 vaccines can be administered at least 6 months after completion of the original vaccines to individuals who are 65 year of age and older, individuals 18 to 64 with a high risk of severe COVID-19, and individuals who may frequently be exposed to the virus that causes COVID-19 such as healthcare workers. Individuals who are interested in receiving a booster vaccine should consult their healthcare provider to determine eligibility.

The FDA approved the booster vaccine based on data from several recent research studies. In one study currently online as a preprint on medRxiv, NIH funded researchers evaluated whether mixing and matching booster vaccinations provided significant immunity against SARS-CoV-2, the virus that causes the COVID-19 disease. In the study, 458 individuals who received a COVID-19 vaccine at least 12 weeks prior were enrolled in the study and received a vaccine different from their original vaccine. Importantly the researchers found that regardless of original vaccine, booster vaccinations increased antibodies against COVID-19. 

Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, stated that the FDA is studying and evaluating whether the booster vaccines can be extended to additional populations and age groups, and they are hoping to have a decision in the coming weeks. Marks said, “we want to make sure that if we deploy the boosters in all of the age ranges, that we truly are making a benefit outweigh any risks.” Regardless, the recent approval of the booster vaccine is an important step forward in ending the COVID-19 pandemic. 

 

Sources: FDAPoliticomedRxiv.

About the Author
  • Science and medical writer | Researcher | Interested in the intersection between translational science, drug development, and policy
You May Also Like
AUG 15, 2021
Coronavirus
A COVID-19 Vaccine Booster Now Recommended for Immunocompromised People
AUG 15, 2021
A COVID-19 Vaccine Booster Now Recommended for Immunocompromised People
As Delta has become the dominant SARS-CoV-2 variant causing COVID-19 infections in the United States, researchers and he ...
SEP 02, 2021
Immunology
Will an Extra COVID Vaccine Shot Benefit People With Autoimmune Conditions?
SEP 02, 2021
Will an Extra COVID Vaccine Shot Benefit People With Autoimmune Conditions?
The global rollout of COVID-19 vaccines has helped save countless lives during the pandemic. Studies have shown that vac ...
SEP 12, 2021
Coronavirus
Real-World, Post-Delta COVID-19 Vaccine Data & Potential Treatment
SEP 12, 2021
Real-World, Post-Delta COVID-19 Vaccine Data & Potential Treatment
New research may have identified a potential treatment or preventive medication for SARS-CoV-2 and other viral infection ...
SEP 14, 2021
Health & Medicine
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
SEP 14, 2021
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
As treatments and infection control practices surrounding COVID-19 continue to evolve, nanotechnological solutions are b ...
NOV 11, 2021
Microbiology
Is Coronavirus Spillover More Common Than We Knew?
NOV 11, 2021
Is Coronavirus Spillover More Common Than We Knew?
While many people are most familiar with the coronavirus that causes COVID-19, which is called SARS-CoV-2, there are man ...
NOV 11, 2021
Health & Medicine
In the Immortal Words of Bob Marley, "Get up! Stand Up!" For Your Mental Health
NOV 11, 2021
In the Immortal Words of Bob Marley, "Get up! Stand Up!" For Your Mental Health
Researchers find extended sitting associated with negative mental health
Loading Comments...